NMNAT1 and peripheral neuropathy: Thus, compensatory changes in other NMNAT isoforms or NMNAT enzyme activity are unlikely to account for our failure to observe alterations in chemotherapy-induced peripheral neuropathy in NMNAT2+/- mice.